Biofortuna

Biofortuna provides molecular diagnostic services. It manufactures a series of HLA and ABO genotyping products for the transplant and hematology markets. The company is also developing antibody screening, genotyping and phenotyping products, genotyping application software, transplant monitoring, and platforms for clinical laboratories, research centers, and point-of-care customers. In addition, Biofortuna Ltd. offers genotyping and custom assay development services. The company was founded in 2008 and is headquartered in Liverpool, UK.